Alector Inc
ALEC1.505USD
+0.055+3.79%
交易中 （美东）报价延迟15分钟
150.49M总市值
亏损市盈率 TTM
关于 Alector Inc 公司
Alector, Inc. 是一家临床阶段的生物技术公司。该公司专注于免疫神经学，这是一种治疗神经退行性疾病的新型治疗方法。该公司致力于开发旨在通过恢复大脑健康免疫功能同时对抗这些病理的疗法。其研究和药物发现平台利用人类基因数据集、生物信息学和成像方面的先进工具以及神经退行性疾病和免疫学方面的见解来识别免疫系统。其候选产品：latozinemab (AL001)、AL002 和 AL101 正在临床开发中。其免疫神经学候选产品得到生物标志物的支持，并寻求治疗包括阿尔茨海默病和基因定义的额颞叶痴呆患者群体在内的适应症。其第一个候选产品 latozinemab 是一种人重组单克隆抗体，可增加 FTD-GRN 患者大脑中的前颗粒蛋白 (PGRN) 水平。
公司简介
公司代码ALEC
公司名称Alector Inc
上市日期Feb 07, 2019
CEODr. Arnon Rosenthal, Ph.D.
员工数量238
证券类型Ordinary Share
年结日Feb 07
公司地址131 Oyster Point Blvd., Suite 600
城市SOUTH SAN FRANCISCO
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编94080
电话14152315660
网址https://alector.com
公司代码ALEC
上市日期Feb 07, 2019
CEODr. Arnon Rosenthal, Ph.D.
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Arnon Rosenthal, Ph.D.
Dr. Arnon Rosenthal, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
5.58M
+2.52%
Dr. Saraswati (Sara) Kenkare-Mitra, Ph.D.
Dr. Saraswati (Sara) Kenkare-Mitra, Ph.D.
President, Head - Research and Development
President, Head - Research and Development
156.08K
+53.99%
Dr. Kristine Yaffe
Dr. Kristine Yaffe
Independent Director
Independent Director
60.41K
+84.69%
Dr. Richard H. Scheller, Ph.D.
Dr. Richard H. Scheller, Ph.D.
Director
Director
56.41K
+103.58%
Dr. Paula Hammond, Ph.D.
Dr. Paula Hammond, Ph.D.
Independent Director
Independent Director
53.91K
+113.85%
Mr. Mark Altmeyer
Mr. Mark Altmeyer
Independent Director
Independent Director
39.01K
+278.29%
Mr. Giacomo Salvadore, M.D.
Mr. Giacomo Salvadore, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Louis J. (Lou) Lavigne, Jr.
Mr. Louis J. (Lou) Lavigne, Jr.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Errol De Souza, Ph.D.
Dr. Errol De Souza, Ph.D.
Independent Director
Independent Director
--
--
Dr. Elizabeth A. (Betsy) Garofalo, M.D.
Dr. Elizabeth A. (Betsy) Garofalo, M.D.
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Arnon Rosenthal, Ph.D.
Dr. Arnon Rosenthal, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
5.58M
+2.52%
Dr. Saraswati (Sara) Kenkare-Mitra, Ph.D.
Dr. Saraswati (Sara) Kenkare-Mitra, Ph.D.
President, Head - Research and Development
President, Head - Research and Development
156.08K
+53.99%
Dr. Kristine Yaffe
Dr. Kristine Yaffe
Independent Director
Independent Director
60.41K
+84.69%
Dr. Richard H. Scheller, Ph.D.
Dr. Richard H. Scheller, Ph.D.
Director
Director
56.41K
+103.58%
Dr. Paula Hammond, Ph.D.
Dr. Paula Hammond, Ph.D.
Independent Director
Independent Director
53.91K
+113.85%
Mr. Mark Altmeyer
Mr. Mark Altmeyer
Independent Director
Independent Director
39.01K
+278.29%
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 5月14日 周三
更新时间: 5月14日 周三
持股股东
股东类型
持股股东
持股股东
占比
Fidelity Management & Research Company LLC
14.39%
Polaris Venture Partners
9.85%
RA Capital Management, LP
9.70%
BlackRock Institutional Trust Company, N.A.
6.41%
The Vanguard Group, Inc.
6.05%
Other
53.59%
持股股东
持股股东
占比
Fidelity Management & Research Company LLC
14.39%
Polaris Venture Partners
9.85%
RA Capital Management, LP
9.70%
BlackRock Institutional Trust Company, N.A.
6.41%
The Vanguard Group, Inc.
6.05%
Other
53.59%
股东类型
持股股东
占比
Investment Advisor
34.87%
Venture Capital
21.09%
Investment Advisor/Hedge Fund
13.63%
Hedge Fund
8.42%
Individual Investor
7.06%
Corporation
3.55%
Research Firm
2.88%
Pension Fund
0.22%
Bank and Trust
0.08%
Other
8.20%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
372
91.63M
91.64%
-20.36M
2025Q1
390
94.05M
94.69%
-22.49M
2024Q4
384
95.68M
96.58%
-16.24M
2024Q3
380
93.59M
96.08%
-7.82M
2024Q2
378
93.92M
97.44%
-5.66M
2024Q1
379
96.98M
102.83%
+4.66M
2023Q4
382
85.51M
101.07%
-5.87M
2023Q3
384
84.61M
100.28%
-2.32M
2023Q2
384
80.93M
96.65%
-6.40M
2023Q1
391
80.04M
96.46%
-3.77M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Fidelity Management & Research Company LLC
14.39M
14.39%
-299.63K
-2.04%
Mar 31, 2025
Polaris Venture Partners
9.85M
9.85%
--
--
Sep 30, 2024
RA Capital Management, LP
9.70M
9.7%
--
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
6.41M
6.41%
-393.95K
-5.79%
Mar 31, 2025
The Vanguard Group, Inc.
6.05M
6.05%
+453.75K
+8.10%
Mar 31, 2025
Rosenthal (Arnon)
5.44M
5.44%
-52.09K
-0.95%
Jun 02, 2025
Merck & Co Inc
3.55M
3.55%
--
--
Mar 31, 2025
Geode Capital Management, L.L.C.
1.96M
1.96%
+47.85K
+2.50%
Mar 31, 2025
State Street Global Advisors (US)
1.64M
1.64%
-209.03K
-11.30%
Mar 31, 2025
J.P. Morgan Securities LLC
1.45M
1.45%
-159.71K
-9.94%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
Invesco NASDAQ Future Gen 200 ETF
0.47%
iShares Neuroscience and Healthcare ETF
0.27%
iShares Micro-Cap ETF
0.03%
Invesco Nasdaq Biotechnology ETF
0.02%
ProShares Ultra Nasdaq Biotechnology
0.02%
iShares Biotechnology ETF
0.01%
iShares Russell 2000 Value ETF
0.01%
iShares Russell 2000 ETF
0%
Fidelity MSCI Health Care Index ETF
0%
JPMorgan Fundamental Data Science Small Core ETF
0%
查看更多
Invesco NASDAQ Future Gen 200 ETF
占比0.47%
iShares Neuroscience and Healthcare ETF
占比0.27%
iShares Micro-Cap ETF
占比0.03%
Invesco Nasdaq Biotechnology ETF
占比0.02%
ProShares Ultra Nasdaq Biotechnology
占比0.02%
iShares Biotechnology ETF
占比0.01%
iShares Russell 2000 Value ETF
占比0.01%
iShares Russell 2000 ETF
占比0%
Fidelity MSCI Health Care Index ETF
占比0%
JPMorgan Fundamental Data Science Small Core ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
